Molina Healthcare Inc

Molina Healthcare is a specialty insurer focused on Medicaid, achieving a +2.3% after-tax margin in a year where industry Medicaid profitability is estimated to be -2%. The company excels at disciplined execution and cost management, resulting in lower costs and higher margins than peers. Molina's management team has successfully turned the company into a low-cost, focused share gainer in Medicaid, with a strong track record of winning RFPs. The longer the Medicaid downturn lasts, the better positioned Molina may be to acquire struggling plans, driving future growth. Molina trades at ~13x 2026 earnings and ~4x our estimate of 2030 earnings, with a projected ~34% 4-year IRR.

Molina Healthcare was the top detractor during the quarter. The U.S.-headquartered managed care company’s stock price declined after it reported challenging second-quarter results and reduced full year earnings per share guidance. This negative revision was caused by cost pressure in the company’s Medicaid and Marketplace businesses. While today’s valuation seems to imply that the headwinds impacting Molina are structural, we believe they’re attributable to temporary factors and expect a meaningful earnings recovery in the coming years.

Molina Healthcare is a leading managed care company and the fourth largest player in managed Medicaid, consistently delivering industry-leading growth and margins. The company's exceptional management team and culture of operational excellence contribute to its strong performance. Molina has significant growth potential through continued share gains in Medicaid and untapped opportunities in Medicare and Marketplace segments. Despite recent pressures from a redeterminations cycle in Medicaid and valuation compression due to policy uncertainty, we believe these earnings pressures are temporary, presenting an opportunity to purchase shares at a meaningful discount to intrinsic value.

Molina Healthcare is a leading managed care company and the fourth largest player in managed Medicaid, consistently delivering industry-leading growth and margins. The exceptional management team and culture of operational excellence contribute to Molina's strong performance. The company has a long runway for growth through continued share gains in Medicaid and untapped opportunities in Medicare and Marketplace segments. Despite recent pressures from a redeterminations cycle in Medicaid and valuation compression due to policy uncertainty, the earnings pressure is viewed as temporary, presenting an opportunity to purchase shares at a meaningful discount to intrinsic value.